Shree Pushkar Chemicals & Fertilizers Ltd
Q1 FY24 Earnings Call Analysis
Chemicals & Petrochemicals
capex: Yesfundraise: Yesrevenue: Category 3margin: Category 1orderbook: Yes
💰fundraise
Any current/future new fundraising through debt or equity?
- No explicit mention of any new fundraising through debt or equity in the recent discussions.
- The planned capex of INR 215 crores is primarily funded through internal accruals and a preferential issue to the promoter (Page 3).
- Solar expansion investment of around INR 37-38 crores is planned without taking any debt or loan (Page 14).
- Current bank borrowings include INR 107 crores, mostly non-funded limits, not additional new debt (Page 7-8).
- No indication of new equity fundraising campaigns or debt issuances was discussed in the Q&A or management remarks.
In summary, the company is funding its capex mainly via internal accruals and promoter preferential issue, with no new debt or equity fundraising currently planned or disclosed.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- Current capex pipeline of approximately INR 200 crores focused on chemical, fertilizer, and renewable energy sectors.
- Around 50-60% of future capacity expansion is towards backward integration, which improves bottom-line without significantly impacting top-line.
- INR 20-22 crores being spent on expanding solar power capacity; total solar investment around INR 37-38 crores with a 3.8 MW plant recently completed and plans for a 9 MW combined solar capacity.
- Capital work in progress (CWIP) closing balance is INR 42 crores — INR 16 crores in solar and INR 33.46 crores in chemical and fertilizer expansions.
- Fertilizer capacity expansions include Unit 6 with 1,50,000 tons and Unit 4 water-soluble fertilizer plant with 12,000 tons capacity, expected to be commercialized in the near term.
- Planned capex of INR 215 crores funded mainly through internal accruals and preferential promoter issue.
📊revenue
Future growth expectations in sales/revenue/volumes?
- For FY25, expected revenue growth is around 15%-20%, targeting approximately INR 875 to INR 935 crores.
- The company anticipates reaching over INR 1,100 crores in revenue by FY26.
- Capacity utilization is expected to improve from 65% to around 75% in FY24-25, enhancing productivity by 10%.
- Volume growth observed in chemicals (26% YoY increase in FY24) and dyes intermediates (82% volume growth in FY24).
- Fertilizer segment expected to support growth, with improved subsidy levels and decent offtake anticipated due to the good monsoon forecast.
- Gradual improvement in business phases: new chemical expansions (Unit 5 and Unit 6) and solar projects to contribute in phases across FY25 and beyond.
- Management expects EBITDA margins to stabilize around 10% in the near term with improved profitability alongside revenue growth.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- The company expects approximately 15%-20% growth in both top line and bottom line for FY25.
- For FY25, a revenue range of INR 875 to INR 935 crores is anticipated.
- For FY26, the company targets a revenue of around INR 1,100 crores.
- EBITDA margin is expected to be around 10% for FY25-26, with cautious optimism given geopolitical factors.
- PAT margins are targeted around 10% in the near term.
- Improvements in fertilizer segment subsidy and expected decent offtake support growth projections.
- Backward integration and solar power project capex will enhance profitability and cost efficiency, positively impacting future earnings.
- Management is confident that operational efficiencies and strategic investments will deliver long-term value and improved earnings visibility soon.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- As of the latest call, the management indicated there is improved visibility on the order book compared to earlier levels.
- The company sees restocking happening on the chemical side, suggesting positive momentum in orders.
- Punit Makharia mentioned that the trust level about order visibility seen in Q4 FY23-24 has been maintained and is expected to improve further in coming quarters.
- No specific numeric values for current or expected order book/pending orders were disclosed during the call.
- The outlook is optimistic, anticipating better demand and growth post the first quarter of FY24-25.
